Basel Medical director files initial Form 3

Basel Medical Group Ltd director Tony Chen filed an initial Form 3 statement of beneficial ownership.

Rhea-AI Filing Summary

Basel Medical Group Ltd director Tony Chen filed an initial Form 3 statement of beneficial ownership. The filing lists him as a director of BMGL but shows no reported transactions or derivative positions in this data, indicating only an initial disclosure of insider status.

Key Figures

Reported buy transactions: 0 Reported sell transactions: 0 Derivative transactions: 0

3 metrics

Reported buy transactions 0 Form 3 transactionSummary buyCount

Reported sell transactions 0 Form 3 transactionSummary sellCount

Derivative transactions 0 Form 3 derivativeTransactionCount

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Basel Medical Group (BMGL) disclose in this Form 3 filing?

The Form 3 identifies Tony Chen as a director of Basel Medical Group Ltd. It functions as an initial statement of beneficial ownership and, in this data, does not list any insider transactions or derivative positions.

Who is the reporting person in Basel Medical Group (BMGL) Form 3?

The reporting person is Tony Chen, identified as a director of Basel Medical Group Ltd. The filing classifies him as a director only, without listing him as an officer or a ten percent owner in this data set.

Does the Basel Medical Group (BMGL) Form 3 show any insider trades?

No insider trades are shown in this Form 3 data. The transaction list is empty and transaction summary counts for buys, sells, and other actions are all zero, reflecting a purely initial ownership disclosure.

Are there any derivative securities reported for Tony Chen in BMGL’s Form 3?

No derivative securities are reported in this Form 3 excerpt. The derivative summary is empty and derivative transaction counts are zero, indicating no options, warrants, or similar instruments are listed for Tony Chen here.

What is the purpose of Basel Medical Group (BMGL) filing this Form 3?

This Form 3 serves as an initial statement of beneficial ownership for director Tony Chen. It formally records his insider status with Basel Medical Group Ltd, even though no specific share holdings or trades appear in the provided data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/14/2026 - 10:25 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

CHEN TONY

(Last) (First) (Middle)

6 NAPIER ROAD,

UNIT #02-10/11 GLENEAGLES MEDICAL CENTRE

(Street)

SINGAPORE 258499

(City) (State) (Zip)

SINGAPORE

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Basel Medical Group Ltd [ BMGL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Tony Chen	04/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)